184 related articles for article (PubMed ID: 33383519)
61. Impact of atopy on asthma and allergic rhinitis in the cohort for reality and evolution of adult asthma in Korea.
Jang AS; Kim SH; Kim TB; Park HW; Kim SH; Chang YS; Lee JH; Cho YS; Park JW; Nahm DH; Cho YJ; Cho SH; Yoon HJ; Choi BW; Moon HB; Park CS;
Allergy Asthma Immunol Res; 2013 May; 5(3):143-9. PubMed ID: 23638312
[TBL] [Abstract][Full Text] [Related]
62. Relationship between amphiregulin and airway inflammation in children with asthma and eosinophilic bronchitis.
Kim KW; Jee HM; Park YH; Choi BS; Sohn MH; Kim KE
Chest; 2009 Sep; 136(3):805-810. PubMed ID: 19447920
[TBL] [Abstract][Full Text] [Related]
63. Improving the diagnosis of eosinophilic asthma.
Coumou H; Bel EH
Expert Rev Respir Med; 2016 Oct; 10(10):1093-103. PubMed ID: 27624868
[TBL] [Abstract][Full Text] [Related]
64. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.
Agache I; Strasser DS; Klenk A; Agache C; Farine H; Ciobanu C; Groenen PM; Akdis CA
Allergy; 2016 Aug; 71(8):1192-202. PubMed ID: 27060452
[TBL] [Abstract][Full Text] [Related]
65. Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
Ciółkowski J; Emeryk A; Hydzik P; Emeryk-Maksymiuk J; Kosmala E; Stasiowska B
Respir Med; 2019 Feb; 147():7-12. PubMed ID: 30704702
[TBL] [Abstract][Full Text] [Related]
66. IL-5 and IL-5 receptor in asthma.
Kotsimbos AT; Hamid Q
Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():75-91. PubMed ID: 9698919
[TBL] [Abstract][Full Text] [Related]
67. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
Gonem S; Berair R; Singapuri A; Hartley R; Laurencin MFM; Bacher G; Holzhauer B; Bourne M; Mistry V; Pavord ID; Mansur AH; Wardlaw AJ; Siddiqui SH; Kay RA; Brightling CE
Lancet Respir Med; 2016 Sep; 4(9):699-707. PubMed ID: 27503237
[TBL] [Abstract][Full Text] [Related]
68. Role of eosinophilic inflammation and atopy in elderly asthmatic patients.
Kawamatawong T; Siripongpun S; Rerkpattanapipat T
Asia Pac Allergy; 2016 Jul; 6(3):181-6. PubMed ID: 27489791
[TBL] [Abstract][Full Text] [Related]
69. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma.
Tran TN; Zeiger RS; Peters SP; Colice G; Newbold P; Goldman M; Chipps BE
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):37-42. PubMed ID: 26707771
[TBL] [Abstract][Full Text] [Related]
70. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.
Takahashi K; Meguro K; Kawashima H; Kashiwakuma D; Kagami SI; Ohta S; Ono J; Izuhara K; Iwamoto I
J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484
[TBL] [Abstract][Full Text] [Related]
71. Sputum basophils are increased in eosinophilic asthma compared with non-eosinophilic asthma phenotypes.
Brooks CR; van Dalen CJ; Hermans IF; Gibson PG; Simpson JL; Douwes J
Allergy; 2017 Oct; 72(10):1583-1586. PubMed ID: 28426171
[TBL] [Abstract][Full Text] [Related]
72. Differential effects of obesity on eosinophilic vs. non-eosinophilic asthma subtypes.
Mukadam S; Zacharias J; Henao MP; Kraschnewski J; Ishmael F
J Asthma; 2018 Jul; 55(7):720-725. PubMed ID: 28846451
[TBL] [Abstract][Full Text] [Related]
73. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
Matucci A; Vultaggio A; Maggi E; Kasujee I
Respir Res; 2018 Jun; 19(1):113. PubMed ID: 29879991
[TBL] [Abstract][Full Text] [Related]
74. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.
Crespo A; Giner J; Torrejón M; Belda A; Mateus E; Granel C; Torrego A; Ramos-Barbón D; Plaza V
J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727
[TBL] [Abstract][Full Text] [Related]
75. Airway inflammation in thunderstorm asthma.
Wark PA; Simpson J; Hensley MJ; Gibson PG
Clin Exp Allergy; 2002 Dec; 32(12):1750-6. PubMed ID: 12653167
[TBL] [Abstract][Full Text] [Related]
76. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).
Schleich F; Brusselle G; Louis R; Vandenplas O; Michils A; Pilette C; Peche R; Manise M; Joos G
Respir Med; 2014 Dec; 108(12):1723-32. PubMed ID: 25456708
[TBL] [Abstract][Full Text] [Related]
77. Clinical characteristics and long-term outcomes related to sputum eosinophilia in Korean asthmatics.
Jung JW; Kim SH; Kwon JW; Kim TW; Kang HR; Park HW; Kim SS; Chang YS; Cho SH; Min KU;
Asia Pac Allergy; 2011 Apr; 1(1):16-24. PubMed ID: 22053292
[TBL] [Abstract][Full Text] [Related]
78. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids.
Godon P; Boulet LP; Malo JL; Cartier A; Lemière C
Eur Respir J; 2002 Dec; 20(6):1364-9. PubMed ID: 12503690
[TBL] [Abstract][Full Text] [Related]
79. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.
Hiles SA; Gibson PG; McDonald VM
Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971
[TBL] [Abstract][Full Text] [Related]
80. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils.
Alvarez-Puebla MJ; Olaguibel Rivera JM; Almudevar E; Echegoyen AA; de Esteban Chocarro B; Cambra K
J Investig Allergol Clin Immunol; 2015; 25(2):107-11. PubMed ID: 25997303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
